You are now being logged in using your Facebook credentials

UKidney: Official Educational Partner of the International Society of Nephrology (ISN)

Login With Facebook
Return to:
Sunday, 25 October 2009 17:04

Supramaximal Dose of Candesartan in Proteinuric Renal Disease

Written by  Dr. Andrew Steele
Rate this item
(0 votes)

Please Note: Audio is available for this presentation

Supramaximal Dose of Candesartan in Proteinuric Renal Disease

Dr. Andrew Steele, Lakeridge Health

Click the movie reel below to begin this presentation


This material is property of the speaker. Any attempted reproduction or rebroadcast without the speaker's permission is not permitted

Read 819 times Last modified on Tuesday, 01 November 2011 20:21
Published in General Nephrology
More in this category: « Sleep Disorders in Patients with Chronic Kidney Disease Proteinuria reduction with ARBs: The DROP Study »

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top